Al Hambra 1 PROGRAM BY HALL...058001 The Newest NOAC in Egypt 229 Prepared by RM Solutions | Page | 1 Al Hambra 1 PROGRAM BY HALL 59 15:00 15:30 Al Hambra 1 …

PROGRAM BY HALLAl Hambra 1

56

13:30

14:00

Al Hambra 1

Medtronic Parallel Symposium

Industry Sponsored Symposium Symposium

Mon 15-2

*ChairpersonAdel El Etriby

Ahmed Elguindy

Amr Zaki

Khaled Shokry

Mohamed Sobhy

Yasser Sadek

1 13:30 13:45 15 min.Ahmad Elsayed Yousef. Ain Shams. Egypt

TAVI Complex case05600129

2 13:45 14:00 15 min.Mohamed Seleem. NHI. Egypt

DAPT and High bleeding risk Patients056002215

57

14:00

14:30

Al Hambra 1

Merck Parallel Symposium


Mon 15-2

*ChairpersonMaged Ramses

Sameh Shaheen

1 14:00 14:30 30 min.Khaled Shokry. Military. Egypt

Royal Control057001168

58

14:30

15:00

Al Hambra 1

Habib “Marcyrl” Parallel Symposium


Mon 15-2


Hosam Hasan

Mohamed El Setiha

Mohamed Ossama

Mohamed Sobhy

1 14:30 15:00 30 min.Nabil Farag. Ain Shams. Egypt

The Newest NOAC in Egypt058001229

Page | 6Prepared by RM Solutions | www.rmsolutions.net


59

15:00

15:30

Al Hambra 1

Diabetes and Cardiometabolic Syndrome Track Session "2" New era of antidiabetics!

Diabetes Track Session

Mon 15-2

*ChairpersonAhmad Mohamed Fathy

Ahmed Yehia

Alaa Etman

Khaled Shokry

Seif Kamal Abou Seif

Tarek Abdelghafar

1 15:00 15:12 12 min.Sameh Emil. Military. Egypt

Position statement for SGLT2i and GLPi from cardiology perceptive

059001260

2 15:12 15:15 3 min.Discussion. .

Discussion059002315

3 15:15 15:27 12 min.Heba Sedrak. Cairo. Egypt

Combining antidiabetics together in cardiac patients, an algorithm from diabetiologist

059003377

4 15:27 15:30 3 min.Discussion. .

Discussion059004315



61

15:30

16:30

Al Hambra 1

Hypertension Track Session "1" How should I treat? (Unusual case scenarios in Hypertension {A}

Hypertension Track Session

Mon 15-2

*ChairpersonAhmed Shawky

Azza Zakaria El Eraky

Farid Dowlah

Fayez Fayek

Lotfy Hamed Abodahab

Nabil Gobran

Ramzy Elmawardy

1 15:30 15:42 12 min.Timoor Mostafa Hassan. Tanta. Egypt

High systolic with low diastolic hypertension, How low is too low??

061001290

2 15:42 15:45 3 min.Discussion. .

Discussion061002315

3 15:45 15:57 12 min.Samy Nouh. Azhar. Egypt

Pseudo resistance, How to detect and treat061003383

4 15:57 16:00 3 min.Discussion. .

Discussion061004315

5 16:00 16:12 12 min.Samia Mahmoud Sharaf El Din. Tanta. Egypt

Autoimmune disease associated with hypertension, the challenge of management

061005384

6 16:12 16:15 3 min.Discussion. .

Discussion061006315

7 16:15 16:27 12 min.Ahmed Farghaly. NHI. Egypt

120/100 how should I manage?061007748

8 16:27 16:30 3 min.Discussion. .

Discussion061008315



63

16:30

17:30

Al Hambra 1

Diabetes and Cardiometabolic| syndrome Track Session "1" Dipping into T2DM


Mon 15-2

*ChairpersonHazem Khorshid

Khalid El Rabbat

Matta Nashid

Mohamed Saad Amin Elgammal

Nosehy Yousef

1 16:30 16:42 12 min.Hesham Elhefnawy. NIDE. Egypt

Remission of T2DM, an illusion or reality? And possible consequences in CVD risk?

063001427

2 16:42 16:45 3 min.Discussion. .

Discussion063002315

3 16:45 16:57 12 min.Ashraf Talat. Damietta. Egypt

T2DM in young and in elderly, is there any message from diabetiologist to cardiologists?

063003843

4 16:57 17:00 3 min.Discussion. .

Discussion063004315

5 17:00 17:12 12 min.Magdy Elmasry. Tanta. Egypt

Do T2DM drugs have CV benfit for Tye 1?063005178

6 17:12 17:15 3 min.Discussion. .

Discussion063006315

7 17:15 17:27 12 min.Inas Shaltout. Cairo. Egypt

Insulin therapy for cardiac patients, diabetiologist message to cardiologist?

063007347

8 17:27 17:30 3 min.Discussion. .

Discussion063008315



68

12:30

13:00

Al Hambra 1

Ecco "Marcyrl" Parallel Symposium


Tue 16-2

*ChairpersonHany Ragy

Hesham Salah Eldin

Mohamed Abdelghany

Mohamed Sobhy

Nabil Farag


risk Reduction in Dyslipidemia Beyond LDL target/ Role of Icosapent ethyl "EPA"

068001229

2 12:45 13:00 15 min.Mohamed Sobhy. Alexandria. Egypt

Are all "EPA-containing products "the same?!068002217

69

13:00

13:30

Al Hambra 1

Parallel Symposium - Sanofi


Tue 16-2

*ChairpersonHamza Kabil

Mohamed Ossama

1 13:00 13:15 15 min.Alaa Etman. NHI. Egypt

Perspectives of ACS management06900151

2 13:15 13:30 15 min.Mohamed Zahran. Ain Shams. Egypt

Does optimization for maximum protection069002220



71

14:30

15:30

Al Hambra 1

Novartis Parallel Symposium


Tue 16-2

*ChairpersonEbtesam Zakaria

Manal Abou Shady

Mohamed Ossama

Nabil Farag

1 14:30 15:00 30 min.Hesham Salah Eldin. Cairo. Egypt

From Legacy to Vision ... 25 Years of Valsartan071001337

2 15:00 15:30 30 min.Hisham El Gayar. Ain Shams. Egypt

Your Patient Future VERIFY’ed071002930



75

17:00

18:00

Al Hambra 1

Smoking Cessation

Smoking Track Session

Tue 16-2

*ChairpersonAdel Shabana

Farid Dowlah

Maged Naeem

Mohamed Hamza Kabil

Talaat Elsayed

Waleed Abbas

1 17:00 17:12 12 min.Hany Ragy. NHI. Egypt

Different Ways of Quitting Smoking?075001128

2 17:12 17:15 3 min.Discussion. .

Discussion075002315

3 17:15 17:27 12 min.Ehab Elkharat. . Egypt

Thirty Seconds could Save Life… The Simple Advice from Healthcare Staff to Dialogue with a Smoking Patient

075003410

4 17:27 17:30 3 min.Discussion. .

Discussion075004315

5 17:30 17:42 12 min.Mahmoud M. Osman. NHI. Egypt

Smoking Cessation and Cardiac Health (Risk Calculations)075005817

6 17:42 17:45 3 min.Discussion. .

Discussion075006315

7 17:45 17:57 12 min.Wael Safwat. . Egypt

Barriers of Quitting Smoking?075007871

8 17:57 18:00 3 min.Discussion. .

Discussion075008315



80

12:30

13:00

Al Hambra 1

MSD Parallel Symposium "Zoom"


Wed 17-2

*ChairpersonHossam Kandil

Ihab Attia


Comprehensive Lipid Management: Tried and True or Something New

080001229

81

13:00

13:30

Al Hambra 1

Biofactor “Marcyrl” Parallel Symposium


Wed 17-2


Hossam Kandil

Nabil Farag

1 13:00 13:15 15 min.Ahmed Shawky. Ain Shams. Egypt

Why is dapagliflozin portfolio a game changer?08100146

2 13:15 13:30 15 min.Ramez Guindy. Ain Shams. Egypt

Rosuvastatin/ Ezetimibe single pill combination; A high Intensity Lipid Lowering Therapy

081002487

83

14:30

15:00

Al Hambra 1

AstraZeneca Parallel Symposium


Wed 17-2

*ChairpersonMansour Moustafa

Moamen Moaz

Soliman Ghareeb

Tarek Naguib

1 14:30 15:00 30 min.Ahmed Magdy. NHI. Egypt

Hypertensive dyslipidemia patients, beyond control with optimum protection

08300134



84

15:00

15:30

Al Hambra 1

Pfizer Biopharmaceutical Parallel Symposium “Virtual"


Wed 17-2

*ChairpersonAhmed Abdellatif Ramadan

Ahmed Mahran

Nosehy Yousef

Salwa Roushdy

1 15:00 15:30 30 min.Ihab Attia. Ain Shams. Egypt

The use of NOACs in special population patients Pfizer084001422

90

12:30

13:00

Al Hambra 1

Pfizer Biopharmaceutical Parallel Symposium “Virtual”


Thu 18-2

*1 12:30 13:00 30 min.Mohamed Sobhy. Alexandria. Egypt

The challenges for current practice for NOACs090001217

91

13:00

13:30

Al Hambra 1

Janseen Parallel Symposium


Thu 18-2

*ChairpersonAhmed Nassar

Mohamed Ossama

1 13:00 13:30 30 min.Nazzareno Galie. . Italy

Triple combination in PAH - Uptravi when and what to Expect091001869

93

14:30

15:00

Al Hambra 1

Liptis Parallel Symposium


Thu 18-2


1 14:30 15:00 30 min.Adel El Etriby. Ain Shams. Egypt

SGLT2 inhibitors a new hope for heart failure treatment09300111



94

15:00

15:15

Al Hambra 1

Scientific Lecture "Endorsed by EvaPharma"


Thu 18-2


Magdy Abdelhamid

1 15:00 15:15 15 min.Sameh Shaheen. Ain Shams. Egypt

AF: 10 Practice essential094001261


PROGRAM BY HALLAl Hambra 1-2

51

8:30

9:30

Al Hambra 1-2

Lipids and Atherosclerosis Session "4" Atherosclerosis

Lipids and Atherosclerosis Session

Mon 15-2

*ChairpersonAshraf Reda

Diaa Elmenshawy

Hamdy Soliman

Sameh Emil

Samir Rafla

1 8:30 8:42 12 min.Galal Al-Kilany. . USA

Multimodality imaging in estimating CVD risk051001864

2 8:42 8:45 3 min.Discussion. .

Discussion051002315

3 8:45 8:57 12 min.Ahmed Aly Elaskary. Sohag. Egypt

Inflammation the co-player in atherosclerosis, An update051003374


Discussion051004315

5 9:00 9:12 12 min.Amir Anwar Aziz. Salam. Egypt

Targeting plaque regression or plaque stabilization?051005896


Discussion051006315


Non-culprit plaques in ACS, Do they have a special care?051007229


Discussion051008315



52

9:30

10:30

Al Hambra 1-2

Heart Failure Track | Session "3" Heart Failure & Diabetes

Heart Failure Track Session

Mon 15-2

*ChairpersonAlaa Mohamed Ibrahim Ali

Bassem Zarif

Magdy Abdelhamid

Mohamed Aboel Kassem

Mohamed Korim

Osama Louis

1 9:30 9:45 15 min.Khaled Leon. NHI. Egypt

Heart failure in diabetics, is it a different entity?052001166


Discussion052002315

3 9:50 10:05 15 min.Francesco Cosentino. . Italy

SGLT2i, Class effect or different individuals…… Data from new trials

052003362

4 10:05 10:10 5 min.Discussion. .

Discussion052004315

5 10:10 10:25 15 min.Petar Seferovic. . Serbia

Treat of Heart Failure in diabetics! Drug treatment and beyond052005363

6 10:25 10:30 5 min.Discussion. .

Discussion052006315



53

10:30

11:30

Al Hambra 1-2

Heart Failure Track | Session "1" A comprehensive review for “chronic heart failure Diagnosis”


Mon 15-2

*ChairpersonAly Saad

Amr Zaki

Doaa A Fouad

Ehab Abdelwahab Hamdy

Ghada Ibrahim Mohamed

Sameh Bakhom

1 10:30 10:45 15 min.Abdalla Al Agha. Cairo. Egypt

The role of Imaging: CMR0530011

2 10:45 10:50 5 min.Discussion. .

Discussion053002315

3 10:50 11:05 15 min.Leila Abid. . Tunisia

The role of Imaging: Echo053003368

4 11:05 11:10 5 min.Discussion. .

Discussion053004315

5 11:10 11:25 15 min.Magdy Abdelhamid. Cairo. Egypt

The role of Biomarkers053005176

6 11:25 11:30 5 min.Discussion. .

Discussion053006315



54

11:30

12:30

Al Hambra 1-2

Coronary Track| Session "1" Antiplatelets therapy. The quest for perfect remedy - All case based

Coronary Track Session

Mon 15-2

*ChairpersonHosam Hasan

Moustafa Mokarrab

Ramzy Elmawardy

Tarek Kafafy

Yasser Elbarbary

1 11:30 11:42 12 min.Yasser Elsayed. Azhar. Egypt

The 2nd antiplatelet choice in 2021054001371

2 11:42 11:45 3 min.Discussion. .

Discussion054002315

3 11:45 11:57 12 min.Adel Hamdy Mahmoud. Minia. Egypt

SAPT or DAPT in chronic AF patients?054003372

4 11:57 12:00 3 min.Discussion. .

Discussion054004315

5 12:00 12:12 12 min.Sherif Hussein. MUST. Egypt

The mechanical valve patient & the post revascularization therapy challenge

054005273

6 12:12 12:15 3 min.Discussion. .

Discussion054006315

7 12:15 12:27 12 min.Wael El Naggar. Cairo. Egypt

When duration counts? Prolonged DAPT, the new evidence054007373

8 12:27 12:30 3 min.Discussion. .

Discussion054008315



55

12:30

13:30

Al Hambra 1-2

Lipids and Atherosclerosis Session "1" Lipids linked CVD risk, An Update


Mon 15-2

*ChairpersonAhmed Aly Elaskary

Ayman Saleh

Hesham Salah Eldin

Khaled Eltohamy

Mohamed Zaki

1 12:30 12:42 12 min.Hatem Elsokkary. Tanta. Egypt

CVD risk stratification to plan lipids management, panoramic view from different guidelines

055001131

2 12:42 12:45 3 min.Discussion. .

Discussion055002315

3 12:45 12:57 12 min.Mohamed Sobhy. Alexandria. Egypt

Lp(a) … Although a lot of data available, yet not an independent risk factors?!

055003217

4 12:57 13:00 3 min.Discussion. .

Discussion055004315

5 13:00 13:12 12 min.Yaser Huzayen. Ain Shams. Egypt

Non-HDL is it just another way to calculate LDL or different parameter?

055005752

6 13:12 13:15 3 min.Discussion. .

Discussion055006315

7 13:15 13:27 12 min.Elsayed Farag. Zagazig. Egypt

Triglycerides and CVD risk, the unsettled issue?!05500795

8 13:27 13:30 3 min.Discussion. .

Discussion055008315



65

8:30

9:30

Al Hambra 1-2

Coronary Track Session "2" How should I treat?


Tue 16-2

*ChairpersonMohamed Saad Amin Elgammal

Montaser M Alcekelly

Tarek Mohamed Abdelrahman

1 8:30 8:42 12 min.Maged Al Abbady. NHI. Egypt

How to assess coronary ischemia, choosing the right test065001313


Discussion065002315

3 8:45 8:57 12 min.Antoine Lafont. . France

Highly positive noninvasive testing in minimally symptomatic patient?

065003403


Discussion065004315

5 9:00 9:12 12 min.Ahmed Bendary. Benha. Egypt

Multivessel revascularization in 2021, from scoring to individualized care

06500525


Discussion065006315

7 9:15 9:27 12 min.Abdelrahman Elbokary. NHI. Egypt

When pregnancy becomes the problem (A rare case scenario)0650075


Discussion065008315



66

9:30

10:30

Al Hambra 1-2

Heart FailureTrack Session "2" An algorithm of management of “Chronic Heart Failure: Comorbidities”


Tue 16-2


Magdy Elmasry

Mahmoud Hassan shah

Montaser M Alcekelly

Salah Atta

Salah Mansour

Walaa Farid


Do co-morbidities affect directly the outcome in HF patients?066001261

2 9:50 10:00 10 min.Discussion. .

Discussion066002315

3 10:00 10:20 20 min.Hadi Skouri. . Lebanon

Cancer: Cardio toxicity induced heart failure, new data066003406

4 10:20 10:30 10 min.Discussion. .

Discussion066004315



67

10:30

11:30

Al Hambra 1-2

Lipids and Atherosclerosis Trak Session "3" Lipids objectives in cardio-metabolic syndrome


Tue 16-2

*ChairpersonAhmed Elbarbary

Gamal Aboul Nasr

Hossam El Masry

Khaled Elkhashab

Samir Rafla

1 10:30 10:42 12 min.Gamela Nasr. Suez Canal. Egypt

Best CVD risk assessment for patients with metabolic 067001110

2 10:42 10:45 3 min.Discussion. .

Discussion067002315

3 10:45 10:57 12 min.Ashraf Reda. Menofia. Egypt

Icosapent Ethyl …evidence data and position statement06700371

4 10:57 11:00 3 min.Discussion. .

Discussion067004315

5 11:00 11:12 12 min.Hesham Salah Eldin. Cairo. Egypt

Fibrates……A position statement in the armamentarium of CVD prevention

067005337

6 11:12 11:15 3 min.Discussion. .

Discussion067006315

7 11:15 11:27 12 min.Ali Eltaher. Sohag. Egypt

Lipid management in NAFLD067007409

8 11:27 11:30 3 min.Discussion. .

Discussion067008315



74

15:30

17:00

Al Hambra 1-2

Coronary Track Session "3" How should I treat? II


Tue 16-2

*ChairpersonAhmed Abdellatif Ramadan

Eman Elsafty

Gamal Aboul Nasr

Khaled Hussein

Waleed Elawady

1 15:30 15:42 12 min.Hosam Hasan. Assiut. Egypt

Building up Optimal Medical Therapy (OMT) for chronic coronary syndrome patient, between inertia and true failure

074001146

2 15:42 15:45 3 min.Discussion. .

Discussion074002315

3 15:45 15:57 12 min.Hazem Khamis. Military. Egypt

FFR guided PCI for elective cases, between preference and obligation.? Long-term outcome data

074003135

4 15:57 16:00 3 min.Discussion. .

Discussion074004315

5 16:00 16:12 12 min.Ayman Aboul Magd. Azhar. Egypt

The dilemma of repeated revascularization, between bad initial choices to more complicated management

07400576

6 16:12 16:15 3 min.Discussion. .

Discussion074006315

7 16:15 16:27 12 min.Filippo Crea. . Italy

The dilemma of microvascular dysfunction in repeated angina, an algorithmic plan of management

074007103

8 16:27 16:30 3 min.Discussion. .

Discussion074008315

9 16:30 16:42 12 min.Sameh Elamin. NHI. Egypt

Hybrid revascularization, in the armamentarium of coronary revascularization therapy at 2021?

074009258

10 16:42 16:45 3 min.Discussion. .

Discussion074010315


PROGRAM BY HALLAl Hambra 1-211 16:45 16:57 12 min.Ahmad Mohamed Fathy. NHI. Egypt

Spontaneous coronary artery dissection management perceptive, case based

07401130

12 16:57 17:00 3 min.Discussion. .

Discussion074012315

72

8:30

9:30

Al Hambra 1-2

Lipids and Atherosclerosis Session "2" Achieving LDL Targets, the tough way to go!


Wed 17-2

*ChairpersonHala Gouda

Waleed Abdou

Yasser Elsayed

1 8:30 8:42 12 min.Alaa Etman. NHI. Egypt

New aggressive targets, should have an evidence?07200151


Discussion072002315

3 8:45 8:57 12 min.Atef El Bahry. Port Said. Egypt

Highest tolerable doses of high intensity statins or combination of statins with ezetimibe from the start?

072003407


Discussion072004315

5 9:00 9:12 12 min.Ihab Attia. Ain Shams. Egypt

PCSK9i …An updated position statement072005422


Discussion072006315

7 9:15 9:27 12 min.Tarek Naguib. Zagazig. Egypt

Statin intolerance, A revisited topic in era of lowest LDL targets072007285


Discussion072008315



77

9:30

10:30

Al Hambra 1-2

Best of National Abstract

Medical Track Session

Wed 17-2

*ChairpersonAly Salah

Hesham Boshra

Medhat Elsayed

Mohamed Sharaby

Nasser Taha

1 9:30 9:38 8 min.Heba Ahmed Hamed. Assiut. Egypt

Safety and efficacy of hydro-mechanical defragmentation in high risk pulmonary embolism

077001914


Discussion077002315


Gender differences in Atherosclerotic cardiovascular disease risk factors in patients with Acute Coronary Syndrome: Updated Data from The Cardiorisk Project

07700325


Discussion077004315

5 9:54 10:02 8 min.Noha Hassanin. Cairo. Egypt

Coronary ostial assessment of Myeloperoxidase level correlated to severity of coronary artery disease.

077005763

6 10:02 10:06 4 min.Discussion. .

Discussion077006315

7 10:06 10:14 8 min.Mostafa Badawy. . Italy

Impact of implanting newly evolving transcatheter heart devices on outcome of patients with severe aortic disease.

077007913

8 10:14 10:18 4 min.Discussion. .

Discussion077008315

9 10:18 10:26 8 min.Salem Rahouma. . Libya

Three Years Libyan Experience in Congenital Heart Disease Interventions

077009915

10 10:26 10:30 4 min.Discussion. .

Discussion077010315



79

10:30

11:30

Al Hambra 1-2

Primary Prevention Track Session 2: Joint session: EgSC and National higher committee for NCDs

Primary Prevention Track Session

Wed 17-2

*ChairpersonGehan Elassal

Hesham Elhefnawy

Khaled Elhadidi

Mohamed Hassani

Mohamed Mashahet

Mohamed Salah

Sameh Shaheen

1 10:30 10:42 12 min.Noha Asem. Cairo. Egypt

NCDs Prevention and Control Strategies- National Experience with International Lessons

079001431

2 10:42 10:45 3 min.Discussion. .

Discussion079002315

3 10:45 10:57 12 min.Randa Abu Elnaga. WHO. Egypt

Opportunistic or mass screening, which is the best to build up meaningful data? Pros and cons

079003432

4 10:57 11:00 3 min.Discussion. .

Discussion079004315

5 11:00 11:12 12 min.Abdellah Abotaleb. NHI. Egypt

Cost Effectiveness of Primary CVD Prevention. A Clear Message for Low-Middle Income Countries

079005433

6 11:12 11:15 3 min.Discussion. .

Discussion079006315

7 11:15 11:27 12 min.Mohamed Hassani. . Egypt

CV complications from antiviral treatment, a national data from virus C campaign

079007426

8 11:27 11:30 3 min.Discussion. .

Discussion079008315



78

15:30

16:00

Al Hambra 1-2

Hypertension Track Session "4" Device Therapy: concurring the Battle


Wed 17-2

*ChairpersonFahmy Sharl

Hassan Shehata

Mahmoud Abdelsabour

Mahmoud Ali Soliman

Mousa Akbar

Saleh Nafea

1 15:30 15:42 12 min.Ahmed Abdullah. . Kuwait

Renal denervation “Is it a true comeback?” A global view on new data for RDT

07800121

2 15:42 15:45 3 min.Discussion. .

Discussion078002315

3 15:45 15:57 12 min.Soliman Ghareeb. Cairo. Egypt

INFRUM device to treat Hypertensive patients078003276

4 15:57 16:00 3 min.Discussion. .

Discussion078004315



86

16:00

17:00

Al Hambra 1-2

Joint Session with WHF


Wed 17-2

*ChairpersonBassem Zarif

Fausto Pinto

Jagat Narula

Karen Sliwa

Khaled Shokry

Magdy Abdelhamid

Mahfouz Elshahawy

Mohamed Ossama

1 16:00 16:12 12 min.Karen Sliwa. . SAF

Air Pollution and CVD: A Brick Wall or a Window of Opportunity?

086001421

2 16:12 16:15 3 min.Discussion. .

Discussion086002315

3 16:15 16:27 12 min.Jagat Narula. . USA

A professional message from cardiologist to primary care physician. The core curriculum of NCDs academy

086003439

4 16:27 16:30 3 min.Discussion. .

Discussion086004315

5 16:30 16:42 12 min.Bassem Zarif. NHI. Egypt

Comprehensive CVD risk control, an updated manual08600585

6 16:42 16:45 3 min.Discussion. .

Discussion086006315

7 16:45 16:57 12 min.David Wood. . UK

Risk factors control between what should be done and what happens? Gap in practice!

086007440

8 16:57 17:00 3 min.Discussion. .

Discussion086008315



87

17:00

18:00

Al Hambra 1-2

Heart Failure Track Session "6" Heart Failure with Preserved Ejection Fraction: Revision the new data!


Wed 17-2

*ChairpersonMagdy Abdelhamid

Mohamed Abdelghany

Mohamed Gamal

Ragab Abdelsalam

Sherif Wagdy

Tarek Elzawawy

Yasser Kamal

1 17:00 17:20 20 min.Petar Seferovic. . Serbia

Heart failure with recovered EF: Definition, diagnosis and management

087001363

2 17:20 17:30 10 min.Discussion. .

Discussion087002315

5 17:30 17:50 20 min.Hany Ragy. NHI. Egypt

Diagnostic imaging and new therapies of Amyloidosis087005128

6 17:50 18:00 10 min.Discussion. .

Discussion087006315



88

8:30

10:00

Al Hambra 1-2

Diabetes and Cardiometabolic syndrome Track Session "3" Diabetes and CV risk assessment


Thu 18-2

*ChairpersonAhmed Abdel Aziz

Amin Fouad

Khaled Elnady

Lobna Abdel Wahid

Raouf Mahran

Said Farkouh

1 8:30 8:42 12 min.Sameh Bakhom. Cairo. Egypt

Do all diabetics have same CVD risk?088001367


Discussion088002315

3 8:45 8:57 12 min.Mahfouz Elshahawy. . USA

My strategy of management in Diabetics in primary and secondary CVD prevention?

088003378


Discussion088004315

5 9:00 9:12 12 min.Fausto Pinto. . Portugal

Diabetics with heart failure, do they need a special care?088005438


Discussion088006315

7 9:15 9:27 12 min.Ehab El Hefny. Azhar. Egypt

Diabetics CV care in coronary artery disease088007345


Discussion088008315

9 9:30 9:42 12 min.Khaled Elnady. Military. Egypt

Diabetics with AF, do they need a special care?088009164


Discussion088010315

11 9:45 9:57 12 min.Seif Kamal Abou Seif. MOH. Egypt

Screening and CV risk scoring for prediabetes when, how and whom?

088011376


PROGRAM BY HALLAl Hambra 1-212 9:57 10:00 3 min.Discussion. .

Discussion088012315



89

10:00

11:30

Al Hambra 1-2

Heart failure Track Session "4" Acute Heart Failure in 2021


Thu 18-2

*ChairpersonAhmed Abdel-Galeel

Ihab Daoud Hanna

Magdy Abdelhamid

Maged Al Abbady

Medhat Elsayed

Mohamed Sobhy

Sameh Emil

1 10:00 10:15 15 min.Bassem Sobhy. . UK

The art to assess congestion in AHF089001446

2 10:15 10:20 5 min.Discussion. .

Discussion089002315

3 10:20 10:35 15 min.Feras Bader. . UAE

“Pharmacological treatment” from ER up to discharge, An update

089003447

4 10:35 10:40 5 min.Discussion. .

Discussion089004315

5 10:40 10:55 15 min.Guisepe Rosano. . UK

“Non-Pharmacological treatment”, Does it work in AHF?089005420

6 10:55 11:00 5 min.Discussion. .

Discussion089006315

7 11:00 11:12 12 min.Hussien Elfishawy. . Egypt

Cardio-renal challenges in management of AHF! Nephrology View

089007448

8 11:12 11:15 3 min.Discussion. .

Discussion089008315

9 11:15 11:27 12 min.Mahmoud Hassanin. Alexandria. Egypt

Cardio-renal challenges in management of AHF! Cardiology View

089009449

10 11:27 11:30 3 min.Discussion. .

Discussion089010315



96

15:30

17:00

Al Hambra 1-2

Heart failure Track| Session 5: Heart Failure with Reduced Ejection Fraction


Thu 18-2

*ChairpersonEmanuel Louka

Khaled Eltohamy

Mahmoud Hassanin

Mohamed Gamal

Nasser Taha

1 15:30 15:50 20 min.Mohamed Hassan. Cairo. Egypt

Debate: Treatment of secondary mitral regurge: percutaneously or surgical; Could it help? Yes it helps

096001204

2 15:50 16:00 10 min.Discussion. .

Discussion096002315


Debate: Treatment of secondary mitral regurge: percutaneously or surgical; Could it help? No it won't

096003215

4 16:20 16:30 10 min.Discussion. .

Discussion096004315

7 16:30 16:50 20 min.Feras Bader. . UAE

Device therapy in HF, in 2021096007447

8 16:50 17:00 10 min.Discussion. .

Discussion096008315



97

17:00

18:00

Al Hambra 1-2

Heart failure Track| Session 8: Patient Journey in Heart Failure


Thu 18-2

*ChairpersonGhada Sayed Youssef

Mohamed Diaa Dardir

Mohamed Zaki

Ossama Sanad

Soha Romeih

Tarek Abo Elazm


A story teller spotting the natural history of the disease.09700125

2 17:15 17:20 5 min.Discussion. .

Discussion097002315


Precious steps to act (prevent/stop HF) between what should be done and what happens?

09700385

4 17:35 17:40 5 min.Discussion. .

Discussion097004315

5 17:40 17:55 15 min.Hany Nematallah. . Egypt

Regenerative therapy in severe CHF097005955

6 17:55 18:00 5 min.Discussion. .

Discussion097006315



202

14:00

15:00

Al Hambra 2

Valvular Management Updates 1


Mon 15-2

*ChairpersonAhmed Elbarbary

Hossam El Masry

Khalid El Rabbat

Magdy Alfons

Mohamed Oraby

1 14:00 14:15 15 min.Osama Refaei. Ain Shams. Egypt

On going inflammatory state in chronic rheumatic heart disease

202001767

2 14:15 14:20 5 min.Discussion. .

Discussion202002315

3 14:20 14:35 15 min.Fathy Maklady. Suez Canal. Egypt

2020 guidelines, what’s new?202003816

4 14:35 14:40 5 min.Discussion. .

Discussion202004315

5 14:40 14:55 15 min.Alaa El Ghamrawy. Mahala. Egypt

Rheumatic Heart Disease, national perceptive202005738

6 14:55 15:00 5 min.Discussion. .

Discussion202006315



60

15:00

15:30

Al Hambra 2

Primary Prevention Track Session "1" Risk Scoring Debate

Preventive cardiology Track Session

Mon 15-2

*ChairpersonFayez Fayek

Hala Gouda

Rehab Ashry


Pro; Scoring Systems Accurately Estimate CVD Risk in Primary Prevention and should be Applied to Everyone

060001378

2 15:12 15:15 3 min.Discussion. .

Discussion060002315

3 15:15 15:27 12 min.Ramez Sam. MOH. Egypt

Contra; Scoring systems is underestimating risk in primary prevention, and shouldn’t be the only way to assess CVD risk in this group

060003379

4 15:27 15:30 3 min.Discussion. .

Discussion060004315



62

15:30

16:30

Al Hambra 2

Primary Prevention Track Session "4" Lifestyle Modifications


Mon 15-2

*ChairpersonKhaled Elnady

Lobna Abdel Wahid

Mohamed Elbahy

1 15:30 15:42 12 min.Gihan Fouad. NNI. Egypt

Diet Control for CVD Prevention, what cardiologists should know?

062001114

2 15:42 15:45 3 min.Discussion. .

Discussion062002315

3 15:45 15:57 12 min.Sherif Azmy. . Egypt

Meat processed, unprocessed and its correlation to CVD risk062003743

4 15:57 16:00 3 min.Discussion. .

Discussion062004315

5 16:00 16:12 12 min.Sameh Thabet. . Egypt

Merits of exercise for CV protection062005745

6 16:12 16:15 3 min.Discussion. .

Discussion062006315

7 16:15 16:27 12 min.Mohamed Eid Morsy. Sohag. Egypt

Intermittent fasting and cardiovascular health062007812

8 16:27 16:30 3 min.Discussion. .

Discussion062008315



64

16:30

17:30

Al Hambra 2

Pulmonary Hypertension and VTE Session "1"

Pulmonary Hypertension and VTE Trac Session

Mon 15-2

*ChairpersonGehan Elassal

Hossam Masoud

Reem Elkorashy

1 16:30 16:42 12 min.Reem Elkorashy. Cairo. Egypt

Pitfalls in management of pulmonary hypertension064001395

2 16:42 16:45 3 min.Discussion. .

Discussion064002315

3 16:45 16:57 12 min.Ahmed Abdel Aziz. NHI. Egypt

Group II pulmonary hypertension not all in one basket064003348

4 16:57 17:00 3 min.Discussion. .

Discussion064004315

5 17:00 17:12 12 min.Youssef Amin. Cairo. Egypt

Insights from Egyptian registry of PH064005398

6 17:12 17:15 3 min.Discussion. .

Discussion064006315

7 17:15 17:27 12 min.Sally Magdy. Cairo. Egypt

Case presentation064007399

8 17:27 17:30 3 min.Discussion. .

Discussion064008315



70

12:30

13:30

Al Hambra 2

Miscellaneous Track: Meet The Experts from Hypertension to Intervention

Miscellaneous Track Session

Tue 16-2


Mohamed Balghith

Mohaned Egred

Tarek Zaki

1 12:30 12:50 20 min.Anastasia Mihailidou. . Australia

Hypertension Guidelines, Gap in evidence070001842

2 12:50 13:00 10 min.Discussion. .

Discussion070002315

3 13:00 13:20 20 min.Mamas Mamas. . UK

LM stening070003501

4 13:20 13:30 10 min.Discussion. .

Discussion070004315



73

14:30

15:30

Al Hambra 2

Primary Prevention Track Session "3" Expanding the role of precision medicine in cardiology; from lifestyle management to genetic therapy


Tue 16-2

*ChairpersonAmal Rizk

Ayman Saleh

Eman Labbany

Mohamed Farid El-Guindy

1 14:30 14:45 15 min.Ahmed Elguindy. AHC. Egypt

Imaging for Risk Assessment, what Cardiologist should know?07300127

2 14:45 14:50 5 min.Discussion. .

Discussion073002315

3 14:50 15:05 15 min.Martha Gulati. . Canada

Prevention ABCD&E073003412

4 15:05 15:10 5 min.Discussion. .

Discussion073004315

5 15:10 15:25 15 min.Yasmine Aguib. AHC. Egypt

Genetic percepctives in CVD prevention073005413

6 15:25 15:30 5 min.Discussion. .

Discussion073006315



76

17:00

18:00

Al Hambra 2

Heart Failure Track Session "7" HF Miscellaneous hot topics


Tue 16-2

*ChairpersonKhaled Elkhashab

Khaled Maghraby

Khalid El Rabbat

Magdy Abdelhamid

Maged Ramses

Mansour Moustafa

1 17:00 17:15 15 min.Guisepe Rosano. . UK

Diagnosis and treatment of myocarditis in 2021076001420

2 17:15 17:20 5 min.Discussion. .

Discussion076002315

3 17:20 17:35 15 min.Karen Sliwa. . SAF

Peripartum cardiomyopathy: New data by the Expert076003421

4 17:35 17:40 5 min.Discussion. .

Discussion076004315

5 17:40 17:55 15 min.Karim Said. Cairo. Egypt

RV: The forgotten chamber in heart failure?076005332

6 17:55 18:00 5 min.Discussion. .

Discussion076006315



82

12:30

13:30

Al Hambra 2

Joint Session with International Delegate Session


Wed 17-2


Haseeb Raza

Yasmin Rustamova

1 12:30 12:38 8 min.Sara Moscatelli. . UK

Women in Cardiology: from cardiovascular diseases in women to gender equality

082001727

2 12:38 12:42 4 min.Discussion. .

Discussion082002315

3 12:42 12:50 8 min.Arash Hashemi. . Iran

Complications in a very complex CTO case082003728

4 12:50 12:54 4 min.Discussion. .

Discussion082004315

5 12:54 13:02 8 min.Assad Samy. NHI. Egypt

PCI Lesson082005750

6 13:02 13:06 4 min.Discussion. .

Discussion082006315

7 13:06 13:14 8 min.Irina Kotlar Velkova. . Macedonia

COVID-related thrombo-embolism in depth082007729

8 13:14 13:18 4 min.Discussion. .

Discussion082008315

9 13:18 13:26 8 min.Fady Gerges. . UAE

How to perform a proper Saline Contrast Echo (SCE) study082009730

10 13:26 13:30 4 min.Discussion. .

Discussion082010315



85

14:30

15:30

Al Hambra 2

Primary Prevention Track Session "5" The Hidden CV Risk


Wed 17-2

*ChairpersonFahmy Sharl

Gamal Aboul Nasr

Khairy Gaballah

Khaled Said Osman

Mohamed Mahmoud Ahmed

Omar Elbahi

Tarek Zaki

1 14:30 14:42 12 min.Omar Khashab. Cairo. Egypt

Uric acid and CVD risk, A position statement085001435

2 14:42 14:45 3 min.Discussion. .

Discussion085002315

3 14:45 14:57 12 min.Maged Tawfik. . Egypt

Autoimmune diseases and CVD risk, how to evaluate individual patient risk?

085003436

4 14:57 15:00 3 min.Discussion. .

Discussion085004315

5 15:00 15:12 12 min.Walaa Adel. Ain Shams. Egypt

Back to basic definitions in CVD prevention, what’s risk marker, risk factor, risk enhancers

085005299

6 15:12 15:15 3 min.Discussion. .

Discussion085006315

7 15:15 15:27 12 min.Ahmed Wafa. Mansoura. Egypt

Beginning of estrogen soon after menopause and CVD prevention, the big question?

08500749

8 15:27 15:30 3 min.Discussion. .

Discussion085008315



92

12:30

13:30

Al Hambra 2

Innovation 2 Session "1" The cardiac innovation in different cardiac fields in the last decade

Innovation Track Session

Thu 18-2

*ChairpersonAmr Zaher

Elsayed AbdelShafie

Gamal Aboul Nasr

Mohamed Helmy

Sameh Elamin

Tarek Khairy

1 12:30 12:50 20 min.Sameh Elamin. NHI. Egypt

The most recent Innovation in different cardiac surgical techniques in the last decade (3D bio-printed heart tissue)

092001258

2 12:50 13:00 10 min.Discussion. .

Discussion092002315

3 13:00 13:20 20 min.Amr Zaher. NHI. Egypt

The Novel power therapy in medicin (the magnet and laser therapy and others)???

09200366

4 13:20 13:30 10 min.Discussion. .

Discussion092004315



95

14:30

15:30

Al Hambra 2

Innovation 2 Session "2" The cardiac innovation in different cardiac fields in the last decade


Thu 18-2

*ChairpersonAlaa Nasr

Ikram Sadek

Khairy Abdel Dayem

Mahmoud Tantawy

Mohamed M. Omran

Mousa Akbar

Sameh Thabet

1 14:30 14:50 20 min.Rabeay Younes Hassan. Zewail University. Egypt

Treatment and prevention of biofilm formation on a complex-shaped metallic implants

095001867

2 14:50 15:00 10 min.Discussion. .

Discussion095002315

3 15:00 15:20 20 min.Ahmed Abdullah. . Kuwait

The noval Robot therapy in the cardiology field (intervention and surgical fields)

09500321

4 15:20 15:30 10 min.Discussion. .

Discussion095004315


PROGRAM BY HALLAl Manial

167

9:00

11:00

Al Manial

Innovation 1 the cardiac innovation in different cardiac fields in the last decade


Mon 15-2

*ChairpersonIhab Daoud Hanna

Khaled Leon

Maged Abdallah

Mohamed Helmy

Nabil Gobran

Sameh Shaheen

William Morris

1 9:00 9:15 15 min.Mohamed Helmy. NHI. Egypt

Introduction for cardiac innovations167001205


Discussion167002315


Innovations in the interventional cardiology materials, machines, and techniques in the last 10 years

167003261


Discussion167004315

5 9:40 9:55 15 min.Ahmed M. Onsy. Ain Shams. Egypt

Innovations in noninvasive cardiology in the last decade16700540


Discussion167006315

7 10:00 10:15 15 min.Mohamed Helmy. NHI. Egypt

The debate around the non-conventional drug therapy (herbal, cup therapy, the acupuncture in the cardiac field)

167007205

8 10:15 10:20 5 min.Discussion. .

Discussion167008315

9 10:20 10:35 15 min.Ihab Daoud Hanna. Italian Hospital. Egypt

The new Innovation in the field of heart failure in the last decade

167009151

10 10:35 10:40 5 min.Discussion. .

Discussion167010315


PROGRAM BY HALLAl Manial11 10:40 10:55 15 min.Amir Anwar Shaker. Kasr El Ainy. Egypt

The most recent Innovations in cardiac drug therapy in the last 10 years

167011898

12 10:55 11:00 5 min.Discussion. .

Discussion167012315

168

11:00

12:00

Al Manial

Cardiac Rehabilitation 1: Should I participate in a cardiac rehab program?


Mon 15-2

*ChairpersonAmal Rizk

Essam Gaber

Laila Shalaby

Omar Awaad

Osama Louis

Osama Sobhy

1 11:00 11:15 15 min.Wael El kilany. Ain Shams. Egypt

Back to Normal life after M1, what the physician should know? Risk stratification for Physical instructions

168001297

2 11:15 11:30 15 min.Adel Shabana. Ain Shams. Egypt

Back to Normal life after M1, what the physician should know? General and specific Mental, moral and social support

16800214

3 11:30 11:45 15 min.Hazem Khorshid. Ain Shams. Egypt

Exercise prescription in CR incorporating what is new in ESC guidelines

168003136

4 11:45 12:00 15 min.Mahmoud El Habiby. . Egypt

Psychiatric Aspects of Cardiac Rehabilitation in Covid-19 Pandemic

168004182



169

12:00

13:00

Al Manial

Pericardium (The missed puzzle piece)


Mon 15-2

*ChairpersonAziz Madkour

Mansour Moustafa

Samia Elkady

1 12:00 12:15 15 min.Hesham Nasr. NHI. Egypt

Pericardial disease, updated treatment options169001323

2 12:15 12:20 5 min.Discussion. .

Discussion169002315

3 12:20 12:35 15 min.Tamer Elashkar. NHI. Egypt

Large Pericardial Effusion; when to drain or refrain??169003359

4 12:35 12:40 5 min.Discussion. .

Discussion169004315

5 12:40 12:55 15 min.Haytham Soliman. Fayoum. Egypt

The real pain for the Cardiologist; Chronic Idiopathic Pericarditis, any remedy?

169005134

6 12:55 13:00 5 min.Discussion. .

Discussion169006315

170

13:00

14:00

Al Manial

Bayer Workshop

Medical Track Workshop

Mon 15-2

*ChairpersonHamza Kabil


Protecting our patients with VTE17000185



171

14:00

15:00

Al Manial

Cardio-Oncology: The Expanding Horizon


Mon 15-2

*ChairpersonAhmad Mohamed Fathy

Amr Ahmed Youssef

Hossam Kandil

Ibtsam Khairat Ibrahim

Walaa Farid

1 14:00 14:15 15 min.Hamza Kabil. Damietta. Egypt

Incidence of events between vitamin K antagonists and direct oral anticoagulants in patients with cancer

171001121

2 14:15 14:20 5 min.Discussion. .

Discussion171002315

3 14:20 14:35 15 min.Ramadan Ghaleb. Aswan. Egypt

The Impact of a multi-disciplinary cardio-oncology program on the cardiovascular outcomes in breast cancer patients

171003619

4 14:35 14:40 5 min.Discussion. .

Discussion171004315

5 14:40 14:55 15 min.Hussien Rizk. Cairo. Egypt

The Need for Precision in Cardio-Oncology; Cardiac aspects of targeted cancer therapy

171005620

6 14:55 15:00 5 min.Discussion. .

Discussion171006315



172

15:00

16:00

Al Manial

Sport Cardiology


Mon 15-2

*ChairpersonMohamed El Maghawry

Mohammad Eltahlawi

Tarek Aziz

Yasser Hosny

1 15:00 15:12 12 min.Hany El Shahidy. NHI. Egypt

Sport Cardiology and Sudden cardiac death in athletes, the unresolved issues

172001488

2 15:12 15:15 3 min.Discussion. .

Discussion172002315

3 15:15 15:27 12 min.Hazem Khamis. Military. Egypt

Pre-participation cardiac assessment172003135

4 15:27 15:30 3 min.Discussion. .

Discussion172004315

5 15:30 15:42 12 min.Gamela Nasr. Suez Canal. Egypt

Echocardiography of athletic heart172005110

6 15:42 15:45 3 min.Discussion. .

Discussion172006315

7 15:45 15:57 12 min.Ahmed Ashraf Eissa. Ain Shams. Egypt

ESC sport Cardiology guidelines, What’s new?17200723

8 15:57 16:00 3 min.Discussion. .

Discussion172008315



173

16:00

17:00

Al Manial

Communication skills: Empower your business and help patients to achieve targets…Effective communication with your patients


Mon 15-2


Fakher Elaouby

Maged Naeem

Nabil Kitchener

Osama Louis

1 16:00 17:00 60 min.Rafaat Yousef. . Egypt

Topic 1 Verbal communications173001629

Topic 2 Non-verbal communicationsTopic 3 Effective negotiation with patientsTopic 4 How to deal with different and difficult types of patient

2 16:00 17:00 60 min.Shereen Metwally. . Egypt

Topic 1 Verbal communications173002630

Topic 2 Non-verbal communicationsTopic 3 Effective negotiation with patientsTopic 4 How to deal with different and difficult types of patient

203

17:00

18:00

Al Manial

Valvular Management Updates 2


Mon 15-2

*ChairpersonAhmed Elhawary

Alaa El Ghamrawy

Hany Fouad Hanna

1 17:00 17:20 20 min.Marwa Mashaal. Kasr El Ainy. Egypt

IE national experience203001740

2 17:20 17:30 10 min.Discussion. .

Discussion203002315

3 17:30 17:50 20 min.Atef El Bahry. Port Said. Egypt

HF in valvular heart disease, an overview203003407

4 17:50 18:00 10 min.Discussion. .

Discussion203004315



174

9:00

10:00

Al Manial

Cardiac Rehabilitation 2: Clinical Nutrition in Cardiac Rehab: Special Concerns


Tue 16-2

*ChairpersonAhmed Abdel Aziz

Alaa Medhat

Ayman Saleh

Hazem Khorshid

Laila Shalaby

Walaa Adel

1 9:00 9:15 15 min.Ahmed Farghaly. NHI. Egypt

Nutritional assessment and Nutritional protocols for post-operative cardiac surgery patient)

174001748

2 9:15 9:30 15 min.Gihan Fouad. NNI. Egypt

Nutritional Intervention in Cardiac patient. Which diet should you choose?

174002114

3 9:30 9:45 15 min.Atef Elsayed Fayed. . Egypt

Factors affecting clinical nutrition in the intensive care unit, especially during the Covid-19 pandemic

17400373

4 9:45 10:00 15 min.Bassem Boulos. . Egypt

Nutrition for mechanically ventilated patients17400484



175

10:00

11:30

Al Manial

Joint Session with Saudi Cardiac Clinical Pharmacists. Clinical Pharmacy: Potential Role in Modern Cardiology


Tue 16-2


Fakher Elaouby

Hatem Elsokkary

Khaled Elnady

Lamia El Wakeel

Mona Schaalan

Naglaa Bazan

1 10:00 10:12 12 min.Walaa Awad. Cairo. Egypt

COVID-19 treatment in CVD, precautions and possible interactions

175001881

2 10:12 10:15 3 min.Discussion. .

Discussion175002315

3 10:15 10:27 12 min.Fakher Elaouby. . KSA

Role of clinical pharmacist In HF clinics175003628

4 10:27 10:30 3 min.Discussion. .

Discussion175004315

5 10:30 10:42 12 min.Eman Elnawasany. Cairo. Egypt

Integrated CVD care, a horizon for true multidisciplinary approach, what clinical pharmacist could do?

175005880

6 10:42 10:45 3 min.Discussion. .

Discussion175006315

7 10:45 10:57 12 min.Naglaa Bazan. Cairo. Egypt

Anti-thrombotic therapy in COVID-19175007860

8 10:57 11:00 3 min.Discussion. .

Discussion175008315

9 11:00 11:12 12 min.Fayez Elshaer. . KSA

Recent updates in pharmacological management of dyslipidemia

175009874

10 11:12 11:15 3 min.Discussion. .

Discussion175010315


PROGRAM BY HALLAl Manial11 11:15 11:27 12 min.Lamia El Wakeel. Ain Shams. Egypt

Updates in cardiovascular medicine, clinical pharmacist percepective

175011879

12 11:27 11:30 3 min.Discussion. .

Discussion175012315

176

12:30

13:30

Al Manial

Bayer Workshop


Tue 16-2

*ChairpersonHazem Khamis

1 12:30 13:30 60 min.Ahmed Shawky. Ain Shams. Egypt

What’s the Comprehensive definition of safety for patients with NVAF?

17600146



177

14:30

15:30

Al Manial

Diagnosing Perioperative Cardiovascular Risks in Non-Cardiac Surgery Patients


Tue 16-2

*ChairpersonMohamed Elgabaly

Nawal Shawky

Sameh Samir

1 14:30 14:42 12 min.Hisham Selim. NHI. Egypt

Precautions and Recommendations for CV Patients and Laparoscopic General Surgery. Anesthesiologist perspective

177001492

2 14:42 14:45 3 min.Discussion. .

Discussion177002315

3 14:45 14:57 12 min.Sayed Abdou. . KSA

Functional vs Structural Assessment, which is better, to stratify your patient?

177003267

4 14:57 15:00 3 min.Discussion. .

Discussion177004315

5 15:00 15:12 12 min.Mahmoud Tantawy. . Egypt

Any Role for Biomarkers before General Surgery of Cardiac Patients??

177005633

6 15:12 15:15 3 min.Discussion. .

Discussion177006315

7 15:15 15:27 12 min.Abdelrahman Elbokary. NHI. Egypt

The Tough Decision for the Cardiologist; PCI before Non-cardiac Surgery. What are the options??

1770075

8 15:27 15:30 3 min.Discussion. .

Discussion177008315



178

15:30

16:30

Al Manial

Women in cardiology


Tue 16-2

*ChairpersonEman El Sharkawy

Ikram Sadek

Kawkab Khedr

Naglaa Mokhtar

Reham M. Darweesh

Sahar Hamdy

Taghreed Helal

Walaa Farid

1 15:30 15:42 12 min.Martha Gulati. . Canada

Women and heart disease: Is there really a sex difference?178001412

2 15:42 15:45 3 min.Discussion. .

Discussion178002315

3 15:45 15:57 12 min.Mahmoud Ali Soliman. Menofia. Egypt

Pregnancy when to advice against and when to terminate, with focus on how to investigate?

178003423

4 15:57 16:00 3 min.Discussion. .

Discussion178004315

5 16:00 16:12 12 min.Nasser Taha. Minia. Egypt

Pregnancy and heart disease: an Egyptian perceptive178005230

6 16:12 16:15 3 min.Discussion. .

Discussion178006315


American Heart Association Program (Go Red for Women in Egypt)

178007488

8 16:27 16:30 3 min.Discussion. .

Discussion178008315



179

16:30

17:30

Al Manial

Best of National Cases, Revise with the experts “1” Coronary Intervention


Tue 16-2

*ChairpersonAntonious Attallah

Azeem Latib

Mamas Mamas

Mohamed Balghith

Osama Shoeib

1 16:30 16:38 8 min.Michael Nagy. AHC. Egypt

Complex high risk indicated patient (CHIP): Choosing LM two stent strategy

179001643

2 16:38 16:42 4 min.Discussion. .

Discussion179002315


Successful procedure .. Do you think? Think again!17900325

4 16:50 16:54 4 min.Discussion. .

Discussion179004315

5 16:54 17:02 8 min.Ibrahim Elsawah. NHI. Egypt

RCA CTO with ambiguous cap179005912

6 17:02 17:06 4 min.Discussion. .

Discussion179006315

7 17:06 17:14 8 min.Ahmed Kassem. . KSA

The Unrecognized POST MI Fatal Complication Despite Successful Rescue Reperfusion

179007908

8 17:14 17:18 4 min.Discussion. .

Discussion179008315


Crushed stent ta the ostium, how behaved at 6 months179009643

10 17:26 17:30 4 min.Discussion. .

Discussion179010315



180

9:00

10:00

Al Manial

Cardiac Rehabilitation 3: Cardiac Rehabilitation in Certain Clinical Conditions


Wed 17-2

*ChairpersonAyman Saleh

Essam Gaber

Hany Abdel Razik

Tarek Aziz

Wael El kilany

Wagdy Galal

1 9:00 9:15 15 min.Walaa Adel. Ain Shams. Egypt

Cardio-oncology rehabilitation for cancer patients and survivors

180001299

2 9:15 9:30 15 min.Osama Louis. NHI. Egypt

Cardiac Rehabilitation in heart failure patients in Covid-19 era: home based management during lockdown

180002239

3 9:30 9:45 15 min.Ahmad Kadry. . Egypt

Cardiac Rehab in elderly heart failure patient18000317

4 9:45 10:00 15 min.Yasser Alaa. . Egypt

Cardiac Telerehabilitation in the era of Covid-19 pandemic180004305



181

10:00

11:00

Al Manial

Pulmonary Hypertension and VTE Session 2

Pulmonary Hypertension and VTE Trac Session

Wed 17-2

*ChairpersonAli Mahmoud Kassem

Kamal Mahmoud

Magdy Matar

Omar Elbahi

William Morris

1 10:00 10:12 12 min.Wael Soliman. Alexandria. Egypt

CTEPH beyond the standard management181001641

2 10:12 10:15 3 min.Discussion. .

Discussion181002315

3 10:15 10:27 12 min.Medhat Abdel khalek. Cairo. Egypt

PAH in ICU181003642

4 10:27 10:30 3 min.Discussion. .

Discussion181004315

5 10:30 10:42 12 min.Youssef Amin. Cairo. Egypt

Pulmonary hypertension in pregnancy181005398

6 10:42 10:45 3 min.Discussion. .

Discussion181006315


Case presentation181007643

8 10:57 11:00 3 min.Discussion. .

Discussion181008315

182

12:30

13:30

Al Manial

Bayer Workshop


Wed 17-2

*ChairpersonMohamed El Setiha


Protecting AF patients undergoing PCI182001215



183

14:30

16:00

Al Manial

Joint Session with ISCVDP


Wed 17-2


Fausto Pinto

Gamela Nasr

Khaled Elnady

Mahfouz Elshahawy

1 14:30 14:45 15 min.Nanette Wenger. . USA

Woman's heart disease183001733

2 14:45 14:50 5 min.Discussion. .

Discussion183002315

3 14:50 15:05 15 min.Ann Curtis. . USA

Atrial Fibrillation current guidelines183003734

4 15:05 15:10 5 min.Discussion. .

Discussion183004315

5 15:10 15:25 15 min.Elizabeth Ofili. . USA

Cardio metabolic syndrom183005735

6 15:25 15:30 5 min.Discussion. .

Discussion183006315

7 15:30 15:45 15 min.Jay Cohn. . USA

Novel approach for cardiovascular disease early detection183007736

8 15:45 15:50 5 min.Discussion. .

Discussion183008315

9 15:50 16:00 10 min.Discussion. .

General discussion between speakers and attendees183009315



184

16:00

17:00

Al Manial

Best of National Cases, Revise with the experts “2” Coronary & Structural Intervention


Wed 17-2

*ChairpersonAntonious Attallah

Ayman Aboul Magd

Mirvat Al Asnag


Trans catheter device closure of ventricular septal rupture postmyocardial infarction with IABPsupport

184001359

2 16:08 16:12 4 min.Discussion. .

Discussion184002315

3 16:12 16:20 8 min.Mostafa Badawy. . Italy

TAVI ; Device migration In LV !184003913

4 16:20 16:24 4 min.Discussion. .

Discussion184004315


Transcatheter device closure of aortic paravalvular leak184005359

6 16:32 16:36 4 min.Discussion. .

Discussion184006315


Something to care about in left main PCI184007643

8 16:44 16:48 4 min.Discussion. .

Discussion184008315

9 16:48 16:56 8 min.Sohil A Elfar. FOMPU. Egypt

Cape of Good Hope route184009921

10 16:56 17:00 4 min.Discussion. .

Discussion184010315



185

17:00

18:00

Al Manial

Joint Session with ESC Heart and Stoke


Wed 17-2


Wolfram Doehner

1 17:00 17:12 12 min.Renate Schnabel. . Germany

Detection of atrial fibrillation after embolic stroke: diagnostic strategies

185001845

2 17:12 17:15 3 min.Discussion. .

Discussion185002315

3 17:15 17:27 12 min.Jan Kovac. . Germany

Training requirements for mechanical thrombectomy in acute stroke – a European perspective

185003846

4 17:27 17:30 3 min.Discussion. .

Discussion185004315

5 17:30 17:42 12 min.Wolfram Doehner. . UK

The role of the Cardiologist on a stroke unit185005847

6 17:42 17:45 3 min.Discussion. .

Discussion185006315


Cerebro-Vascular complications in cardiac patients, an overview

18500785

8 17:57 18:00 3 min.Discussion. .

Discussion185008315


PROGRAM BY HALLAL Montaza 2-3-411 17:26 17:30 4 min.Discussion. .

Discussion126011315

132

9:30

10:30

AL Montaza 2-3-4

Session 2: Hypertension guidelines


Thu 18-2

*ChairpersonMahmoud Abdelsabour

Marwa Mohamed gad

Mohsen Ibrahim

Omar Awaad

Samia Mahmoud Sharaf El Din

1 9:30 9:42 12 min.Ahmed Abdel Rahman. Ain Shams. Egypt

ISH 2020 guidelines, Is there any new message?13200119


Discussion132002315

3 9:45 9:57 12 min.Ramez Guindy. Ain Shams. Egypt

Guidelines and Gap in Evidence132003487


Discussion132004315

5 10:00 10:12 12 min.Hatem Elsokkary. Tanta. Egypt

The missing part of the puzzle, Message from guidelines to stakeholders

132005131

6 10:12 10:15 3 min.Discussion. .

Discussion132006315

7 10:15 10:27 12 min.Omar Awaad. Ain Shams. Egypt

Whether American and European can be applied in Egypt?132007233

8 10:27 10:30 3 min.Discussion. .

Discussion132008315


PROGRAM BY HALLAL Montaza 2-3-4

133

10:30

11:30

AL Montaza 2-3-4

CPR in the armamentarium of cardiac patient care


Thu 18-2

*ChairpersonKhaled Elkhashab

Khalid El Rabbat

Magdy Matar

Salwa Roushdy


CPR in Covid19 " AHA guidlines 2020 "133001488

2 10:40 10:42 2 min.Discussion. .

Discussion133002315

3 10:42 10:52 10 min.Mohamed Gharieb. NCHI. Egypt

CPR in Cath Lab133003334

4 10:52 10:54 2 min.Discussion. .

Discussion133004315

5 10:54 11:04 10 min.Tarek El Khouly. NHI. Egypt

CPR recent update133005282

6 11:04 11:06 2 min.Discussion. .

Discussion133006315

7 11:06 11:16 10 min.Yasser Hosny. Benha. Egypt

CPR in Atheletes in COVID19 Era133007489

8 11:16 11:18 2 min.Discussion. .

Discussion133008315

9 11:18 11:28 10 min.Yasser Yazid. . Egypt

CPR in special Situation133009490

10 11:28 11:30 2 min.Discussion. .

Discussion133010315



134

12:30

13:30

AL Montaza 2-3-4

Cardio-Covid - Session "1" From pathogenesis to diagnosis “All the story of cardio-virology”


Thu 18-2

*ChairpersonDiaa Elmenshawy

Ragab Abdelsalam

Sherif Seif

Tarek Abdelghafar

1 12:30 12:45 15 min.Wael El kilany. Ain Shams. Egypt

Myo- pericarditis134001297

2 12:45 12:50 5 min.Discussion. .

Discussion134002315

5 12:50 13:05 15 min.Nasser Taha. Minia. Egypt

Arterial affection the whole spectrum134005230

6 13:05 13:10 5 min.Discussion. .

Discussion134006315

7 13:10 13:25 15 min.Mohamed Abdel Shafy. Benha. Egypt

Veneous thrombo-embolism134007494

8 13:25 13:30 5 min.Discussion. .

Discussion134008315



135

14:30

15:30

AL Montaza 2-3-4

Cardio-Covid - Session "2" The good, the bad and the ugly in Cardio-COVID management


Thu 18-2

*ChairpersonGamal Aboul Nasr

Hassan Baky

Mohamed Wafaie Aboul Enien

Nady Michel

Ramez Sam

1 14:30 14:42 12 min.Tamer Moustafa. Zagazig. Egypt

Triage both COVID-19 and cardiac problems, an algorithmic approach

135001279

2 14:42 14:45 3 min.Discussion. .

Discussion135002315

3 14:45 14:57 12 min.Ghada Kazamel. NHI. Egypt

Management of COVID-19 between healthcare teams135003112

4 14:57 15:00 3 min.Discussion. .

Discussion135004315

5 15:00 15:12 12 min.Mahmoud Hassanin. Alexandria. Egypt

Late and very late COVID-19 CVD complication, an alertness call

135005449

6 15:12 15:15 3 min.Discussion. .

Discussion135006315

7 15:15 15:27 12 min.Victor Fadlallah. NHI. Egypt

Corticosteroids and anticoagulation? When, how and to whom?

135007462

8 15:27 15:30 3 min.Discussion. .

Discussion135008315



136

15:30

16:00

AL Montaza 2-3-4

Cardio-Covid - Session "3"


Thu 18-2

*ChairpersonHamdy Soliman

Khaled Elnady

Khaled Shokry

Samir Rafla


A state of art lecture: Cardiovascular Disease in Pandemic Times

136001438



137

16:00

17:00

AL Montaza 2-3-4

TeleHealth


Thu 18-2

*ChairpersonLaila Shalaby

Magdy Alfons

Taghreed Sharaf

Waleed Abbas

1 16:00 16:12 12 min.Nader Tadross. . USA

Shaking the Medical Care Paradigm, lessons from COVID-19 eraFaculty affiliations in several US medical institutions

137001498

2 16:12 16:15 3 min.Discussion. .

Discussion137002315

3 16:15 16:27 12 min.Shehab Anwar. . Switzerland

Patients communication platforms137003499

4 16:27 16:30 3 min.Discussion. .

Discussion137004315

5 16:30 16:42 12 min.Shehab Anwar. . Switzerland

State of art in the interpretation of cardiac imaging by machine learning

137005499

6 16:42 16:45 3 min.Discussion. .

Discussion137006315

7 16:45 16:57 12 min.Mamas Mamas. . UK

Electronic health records: a limitation of retrospective data or a potential information mine

137007501

8 16:57 17:00 3 min.Discussion. .

Discussion137008315



138

17:00

18:00

AL Montaza 2-3-4

Best of National Cases, Revise with the experts “3” Clinical Scenario


Thu 18-2

*ChairpersonAhmed Nassar

Mohaned Egred

Wael El kilany

Waleed Abbas

1 17:00 17:10 10 min.Hoda Shehata. Alexandria. Egypt

From Stuck to Rocking138001761

2 17:10 17:15 5 min.Discussion. .

Discussion138002315

3 17:15 17:25 10 min.Amir Anwar Shaker. Kasr El Ainy. Egypt

Looking beyond the coronaries138003898

4 17:25 17:30 5 min.Discussion. .

Discussion138004315

5 17:30 17:40 10 min.Aly Tohamy. Assiut. Egypt

Obstruction of non obstructive plaque138005907

6 17:40 17:45 5 min.Discussion. .

Discussion138006315

7 17:45 17:55 10 min.Wael M. Qenawi. . KSA

Rare but serious adverse event of warfarin138007920

8 17:55 18:00 5 min.Discussion. .

Discussion138008315


PROGRAM BY HALLAbdeen

139

8:30

9:30

Abdeen

Hypertension Track Session "5" How should I treat? 2


Thu 18-2

*ChairpersonCharl Boshra

George Ghaly

Mohamed Abdelwahab Ezat

Mohamed Bordy

Taghreed Helal

1 8:30 8:45 15 min.Ossama Sanad. Benha. Egypt

Diuretics Vs CCBs for initial combination therapy (on top of RAASi)

139001240


Discussion139002315

3 8:50 9:05 15 min.Ahmed Galal. NHI. Egypt

Resistant Hypertension. Updated guidelines review (Achieving control or changing the goal).

139003506


Discussion139004315

5 9:10 9:25 15 min.Maged Abdallah. Mataria. Egypt

New molecules for treating Resistant Hypertension... Novel drugs

139005883


Discussion139006315



140

9:30

10:30

Abdeen

Diabetes and Cardiometabolic syndrome Track Session "4" Cardiometabolic syndrome


Thu 18-2

*ChairpersonAdel Abdelaziz

Adel El Etriby

Nada Hamed

Nawal Shawky

Nosehy Yousef

1 9:30 9:42 12 min.Andreas Zirlik. . Germany

Hypertriglyceridemia and CVD risk…. A position statement140001511


Discussion140002315


Epicardial fat, a part of visceral obesity or a specific risk factor?140003378


Discussion140004315


Management of CVD risk in metabolic syndrome, Priorities and algorithm

140005438

6 10:12 10:15 3 min.Discussion. .

Discussion140006315

7 10:15 10:30 15 min.Discussion. .

General Discussion140007315



141

10:30

11:30

Abdeen

HypertensionTrack Session "3" Secondary Hypertension


Thu 18-2

*ChairpersonAnastasia Mihailidou

Hazem Farrag

Magdy Abdelsamie

Mahmoud Ali Soliman

Tarek Naguib

Waleed Abdou

1 10:30 10:45 15 min.Sherif Wagdy. Alexandria. Egypt

Patients’ profile and when to suspect early?141001441

2 10:45 10:50 5 min.Discussion. .

Discussion141002315

3 10:50 11:05 15 min.Azza Zakaria El Eraky. Port Said. Egypt

Most seen scenarios in daily practice and the art of handling investigations

141003380

4 11:05 11:10 5 min.Discussion. .

Discussion141004315

5 11:10 11:25 15 min.Ali Mahmoud Kassem. Sohag. Egypt

Secondary Hypertension, chance of normalization of BP on controlling the cause and overall prognosis, what literatures say?

141005640

6 11:25 11:30 5 min.Discussion. .

Discussion141006315



142

12:30

13:30

Abdeen

Cardiology! Medicolegal Prespectives


Thu 18-2

*ChairpersonAziz Madkour

Hassan Baky

Khaled Hussein

Mohamed Ossama

Salwa Roushdy

1 12:30 12:42 12 min.Abdelmoty Kabbash. Tanta. Egypt

Can I make a claim for medical negligence?142001515

2 12:42 12:45 3 min.Discussion. .

Discussion142002315

3 12:45 12:57 12 min.Rabab El kelany. Tanta. Egypt

Medical Errors categorization and prophylactic strategy142003516

4 12:57 13:00 3 min.Discussion. .

Discussion142004315

5 13:00 13:12 12 min.Amal Saeed. Tanta. Egypt

Medical Negligence in cardiology: common pitfalls142005518

6 13:12 13:15 3 min.Discussion. .

Discussion142006315

7 13:15 13:27 12 min.Marwa Shahin. Alexandria. Egypt

ي142007المسؤولية القانونية للطبيب والمستشف

517

8 13:27 13:30 3 min.Discussion. .

Discussion142008315



143

14:30

18:30

Abdeen

Research


Thu 18-2

*1 14:30 15:15 45 min.Noha Asem. Cairo. Egypt

Translating Research Into practice143001431

2 15:15 15:45 30 min.Ihab Yassin. NHI. Egypt

Overview of study Design143002519

3 15:45 16:30 45 min.Mohamed Bendary. Cairo. Egypt

Basics of Biostatistics143003520

4 16:30 17:00 30 min.Aisha Elsharkawy. Cairo. Egypt

What you need to know about journals143004872

5 17:00 17:30 30 min.Mohamed Elboraey. Azhar. Egypt

Manuscript writing: made easy143005873

6 17:30 18:30 60 min.Noha Asem. Cairo. Egypt

Workshop143006431


PROGRAM BY HALLSans Souci 1

206

12:30

13:15

Sans Souci 1

Best of call for science @cardioegypt 2021


Thu 18-2

*ChairpersonEman Labbany

Osama Sobhy

Reham M. Darweesh

1 12:30 12:40 10 min.Antonella Sabatini. . USA

Metabolic Syndrome206001924

2 12:40 12:45 5 min.Discussion. .

Discussion206002315


Atherosclerotic risk factors’ profile and management strategies in diabetic patients with acute coronary syndrome: an analysis from the Egyptian CardioRisk project

20600325

4 12:55 13:00 5 min.Discussion. .

Discussion206004315

5 13:00 13:10 10 min.Rafik Soliman. Menofia. Egypt

Rare causes for IHD Giant LAD aneurysm associated with large RV fistula

206005940

6 13:10 13:15 5 min.Discussion. .

Discussion206006315


PROGRAM BY HALLSans Souci 1

208

14:30

15:30

Sans Souci 1

Best of call for science @cardioegypt 2021


Thu 18-2

*ChairpersonAmal Abdel Salam

Khaled Leon

Maged Al Abbady

1 14:30 14:40 10 min.Paula Shohdy. Suez Canal. Egypt

Nothing worse having a stiff heart208001960

2 14:40 14:45 5 min.Discussion. .

Discussion208002315

3 14:45 14:55 10 min.Sherif Mohammad Abd Elsamad. Alexandria. Eg

Two holes to cover208003959

4 14:55 15:00 5 min.Discussion. .

Discussion208004315

5 15:00 15:10 10 min.Victor Fadlallah. NHI. Egypt

Ostial LAD selective intervention is it still a debate or a disaster208005462

6 15:10 15:15 5 min.Discussion. .

Discussion208006315

7 15:15 15:25 10 min.Shehab Adel El Etriby. Ain Shams. Egypt

It’s not always as easy as it looks208007837

8 15:25 15:30 5 min.Discussion. .

Discussion208008315


Documents

Al Hambra 1 PROGRAM BY HALL...058001 The Newest NOAC in Egypt 229 Prepared by RM Solutions | Page | 1 Al Hambra 1 PROGRAM BY HALL 59 15:00 15:30 Al Hambra 1 …